《生物化學(xué)工程雜志》旨在促進(jìn)生物工藝發(fā)展的關(guān)鍵化學(xué)工程方面的進(jìn)展，從原材料制備到與醫(yī)療/保健、工業(yè)生物技術(shù)和環(huán)境生物技術(shù)等不同行業(yè)相關(guān)的產(chǎn)品回收。該雜志歡迎以下研究領(lǐng)域的全文原創(chuàng)研究論文、簡短的交流和評論論文*：生物催化（酶或微生物）和生物轉(zhuǎn)化，包括固定化生物催化劑的制備和動力學(xué)。生物傳感器和生物制品，包括生物合成和新型燃料電池開發(fā)。生物分離，包括放大和蛋白質(zhì)再折疊/再飽和。環(huán)境生物工程，包括生物轉(zhuǎn)化、生物修復(fù)和微生物燃料電池。生物反應(yīng)器系統(tǒng)，包括特性描述、優(yōu)化和放大。生物資源和生物精煉工程，包括生物量轉(zhuǎn)化、生物燃料、生物能源和優(yōu)化。工業(yè)生物技術(shù)，包括特種化學(xué)品、平臺化學(xué)品和中性藥物。生物材料和組織工程，包括生物人工器官、細(xì)胞封裝和控制釋放。細(xì)胞培養(yǎng)工程（植物、動物或昆蟲細(xì)胞），包括病毒載體、單克隆抗體、重組蛋白、疫苗和次級代謝產(chǎn)物。細(xì)胞療法和干細(xì)胞，包括多能干細(xì)胞、間充質(zhì)干細(xì)胞和造血干細(xì)胞；免疫療法；組織特異性分化和冷凍保存。代謝工程、系統(tǒng)和合成生物學(xué)，包括解剖學(xué)、生物信息學(xué)、硅生物學(xué)和代謝通量分析。蛋白質(zhì)工程包括酶工程和定向進(jìn)化。*在提交評論文章之前，作者需要填寫一份評論建議表以供編輯批準(zhǔn)。提案可以提交給John Coca先生（j.coca@elsevier.com）或其中一位編輯。

The Biochemical Engineering Journal aims to promote progress in the crucial chemical engineering aspects of the development of biological processes associated with everything from raw materials preparation to product recovery relevant to industries as diverse as medical/healthcare, industrial biotechnology, and environmental biotechnology.The Journal welcomes full length original research papers, short communications, and review papers* in the following research fields:Biocatalysis (enzyme or microbial) and biotransformations, including immobilized biocatalyst preparation and kineticsBiosensors and Biodevices including biofabrication and novel fuel cell developmentBioseparations including scale-up and protein refolding/renaturationEnvironmental Bioengineering including bioconversion, bioremediation, and microbial fuel cellsBioreactor Systems including characterization, optimization and scale-upBioresources and Biorefinery Engineering including biomass conversion, biofuels, bioenergy, and optimizationIndustrial Biotechnology including specialty chemicals, platform chemicals and neutraceuticalsBiomaterials and Tissue Engineering including bioartificial organs, cell encapsulation, and controlled releaseCell Culture Engineering (plant, animal or insect cells) including viral vectors, monoclonal antibodies, recombinant proteins, vaccines, and secondary metabolitesCell Therapies and Stem Cells including pluripotent, mesenchymal and hematopoietic stem cells; immunotherapies; tissue-specific differentiation; and cryopreservationMetabolic Engineering, Systems and Synthetic Biology including OMICS, bioinformatics, in silico biology, and metabolic flux analysisProtein Engineering including enzyme engineering and directed evolution*Authors are requested to complete a Review Proposal Form for Editorial approval prior to submission of the review article. Proposals can be submitted to Mr. John Coca (j.coca@elsevier.com) or one of the Editors.